Catalent Archives - Express Pharma

Pharma dose CMOs face growth slowdown, but opportunities lie ahead

Pharma CMO M&A activity shifts focus to scaling in 2023: GlobalData

Catalent to help Novo Nordisk address production demands for Ozempic and Wegovy: GlobalData

M&A activity of pharma CMOs will continue despite challenging borrowing environment: GlobalData

Moderna and Catalent announce collaboration for COVID-19 vaccine candidate